Previous close | 225.73 |
Open | 225.00 |
Bid | 225.68 x 800 |
Ask | 226.70 x 800 |
Day's range | 219.15 - 228.56 |
52-week range | 64.88 - 290.23 |
Volume | 7,422,610 |
Avg. volume | 3,478,916 |
Market cap | 43.35B |
Beta (5Y monthly) | 0.87 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.19 |
Earnings date | 11 Mar 2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 278.41 |
DocuSign (DOCU) closed the most recent trading day at $226.66, moving +0.41% from the previous trading session.
The stock market's volatility continued on Thursday, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) felt the brunt of the damage. As of 1:45 p.m. EST, the Nasdaq was down more than 2.5%, which was the worst performance of any of the major U.S. stock market benchmarks. Amid high-profile tech stocks with recurring revenue models, DocuSign (NASDAQ: DOCU) gave back some of its recent gains.
There's little doubt that the digital signature market got a big boost from the pandemic, and as the industry leader, DocuSign (NASDAQ: DOCU) was a major beneficiary. During the first nine months of 2020, revenue grew 46% year over year, while the company's operating loss edged lower. While DocuSign's dominance of the e-signature space still represents a significant market opportunity, there's another one that's just as big waiting in the wings.